4
Changes in Ownership
Rani Therapeutics Holdings, Inc. Filed Acc 0001209191-22-021022
Chief Executive Officer acquired 86,600 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Imran Talat Chief Executive Officer | 2022-03-22 | Grant or award | +86,600 | 98,943 | D: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Imran Talat Chief Executive Officer | 2022-03-22 | Grant or award · Stock Option (Right to Buy) | +263,400 | 263,400 | D: show line 2 in the form |
Loading xslF345X03/doc4.xml…